See also this year's filing and all EDGAR filings for this company.
PDF Report 0001656536_2022_Decibel_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'100030 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) 2': 3, '100040 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)': 17}} |
Graph
Absolute values for 0001656536, Decibel Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 164,191,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 5,611,000 |
| 3 | remainder_Assets | 14,675,000 |
| 4 | LiabilitiesCurrent | 20,538,000 |
| 5 | LiabilitiesNoncurrent | 1,611,000 |
| 6 | remainder_Liabilities | 20,639,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 20,384,000 |
| 9 | ResearchAndDevelopmentExpense | 29,847,000 |
| 10 | remainder_Expenses | 1,797,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 205,000 |
| 13 | remainder_ComprehensiveNetIncome | -131,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 184,477,000 |
| 1 | Liabilities | 42,788,000 |
| 2 | Expenses | 52,028,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 141,689,000 |
| 5 | NetIncome | -51,823,000 |
| 6 | ComprehensiveNetIncome | -51,888,500 |
| 7 | BaseVar | 139,814,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.26 |
| 9 | EconomicCapitalRatio | 3.20 |
Edgar->Model Mapping
Feature Distribution
